PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 28854096
OWN - NLM
STAT- MEDLINE
DA  - 20170830
DCOM- 20170905
LR  - 20170906
IS  - 1533-4406 (Electronic)
IS  - 0028-4793 (Linking)
VI  - 377
IP  - 9
DP  - 2017 Aug 31
TI  - Targeting the Colorectal Cancer Stem Cell.
PG  - 888-890
LID - 10.1056/NEJMcibr1706541 [doi]
FAU - Medema, Jan Paul
AU  - Medema JP
AD  - From the Laboratory of Experimental Oncology and Radiobiology, Cancer Center
      Amsterdam, Academic Medical Center, Amsterdam.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
RN  - 0 (Antineoplastic Agents)
RN  - 0 (LGR5 protein, human)
RN  - 0 (Lgr5 protein, mouse)
RN  - 0 (Receptors, G-Protein-Coupled)
RN  - PQX0D8J21J (Cetuximab)
SB  - AIM
SB  - IM
MH  - Animals
MH  - Antineoplastic Agents/pharmacology/therapeutic use
MH  - Cell Dedifferentiation
MH  - Cetuximab/pharmacology/therapeutic use
MH  - Colon/*cytology
MH  - Colorectal Neoplasms/drug therapy/genetics/*pathology
MH  - Disease Models, Animal
MH  - *Gene Knock-In Techniques
MH  - Humans
MH  - Mice
MH  - Molecular Targeted Therapy
MH  - Neoplastic Stem Cells/drug effects/*physiology
MH  - Receptors, G-Protein-Coupled/*genetics/metabolism
EDAT- 2017/08/31 06:00
MHDA- 2017/09/07 06:00
CRDT- 2017/08/31 06:00
AID - 10.1056/NEJMcibr1706541 [doi]
PST - ppublish
SO  - N Engl J Med. 2017 Aug 31;377(9):888-890. doi: 10.1056/NEJMcibr1706541.